Cargando…
Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
Breast cancer is one of the leading causes of death in women in the United States. In general, patients with breast cancer undergo surgical resection of the tumor and/or receive drug treatment to kill or suppress the growth of cancer cells. In this regard, small molecule kinase inhibitors serve as a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
OAE Publishing Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100881/ https://www.ncbi.nlm.nih.gov/pubmed/32226926 http://dx.doi.org/10.20517/cdr.2019.100 |